GlassScriptPhysician profile
Kinga K Pluta
NPI 1679549505
$3,861.51
in general payments reported to CMS, 2019-2025
13 companies · $697 in 2025
The $697 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,355 · 2020: $116 · 2021: $110 · 2022: $70.58 · 2023: $104 · 2024: $407 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.50 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $1,353.74 | 2019 | |
| Abbott Laboratories | $710.64 | 2019-2020 | |
| Dexcom, INC. | $541.82 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Tandem Diabetes Care, INC. | $339.81 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $327.94 | 2019-2025 | |
| Corcept Therapeutics | $144.03 | 2025 | Korlym |
| Senseonics, Incorporated | $71.00 | 2019 | |
| Lilly USA, LLC | $70.89 | 2019-2022 | |
| Mannkind Corporation | $69.17 | 2025 | |
| Novo Nordisk INC | $66.72 | 2021 | |
| Beta Bionics, INC. | $63.38 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Cequr Corporation | $60.52 | 2022-2023 | Cequr Simplicity |
| Novartis Pharmaceuticals Corporation | $41.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinga Pluta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.